Atlas Trials

Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions

Clinical trial NCT03226470 · UNKNOWN

Trial details

NCT number
NCT03226470
Sponsor
Huazhong University of Science and Technology
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Human Papillomavirus-Related Malignant Neoplasm
Start date
2017-03-10
Primary completion
2022-02-10
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.